Results 211 to 220 of about 4,645,684 (346)

Evaluation of Public Art - Frameworks, Logic Models and Emerging Impact [PDF]

, 2010
Strange, I, Usher, D
core  

Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz, Carolin Otto, Klemens Ruprecht, Susanna Asseyer, Hannes Ole Tiedt, Christian Meisel, Judith Bellmann‐Strobl, Friedemann Paul, Patrick Schindler   +8 more
wiley   +1 more source

Older people's day centres' preventive work: views of day centre providers and their stakeholders. [PDF]

Int J Qual Stud Health Well-being
Samsi K, Orellana K.
europepmc   +1 more source

Functional Characterization and Pathogenicity Classification of PRRT2 Splice Variants in PRRT2‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Paroxysmal kinesigenic dyskinesia (PKD) is the most common hereditary paroxysmal movement disorder. The PRRT2 gene is the first identified causative gene and accounts for the majority of PKD. In this study, we investigated the pathogenicity of PRRT2 variants in the splice regions. Methods Patients with clinically suspected PKD and no
Jiao‐Jiao Xu, Yu‐Lan Chen, Wan‐Bing Sun, Hong‐Fu Li, Zhi‐Ying Wu, Dian‐Fu Chen   +5 more
wiley   +1 more source

Usability testing a web application to support evidence-based commissioning decisions for implementing mobile stroke units. [PDF]

NPJ Digit Med
Moseley L, Laws A, Allen M, Ford GA, James M, McCarthy S, McClelland G, Park LJ, Pearn K, Phillips D, Price C, Shaw L, White P, Wilson D, McMeekin P, Scott J.   +15 more
europepmc   +1 more source

Retro-Commissioning Phase I Demonstration Project Shanghai, China

, 2006
Peter Keithly
openalex   +1 more source

Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi   +12 more
wiley   +1 more source

Mediators implementation and delivery: the falls management exercise programme (FaME). [PDF]

BMC Health Serv Res
Manning F, Ventre JP, Brough G, Hawley-Hague H, Hulme C, Kendrick D, Logan P, Mahmoud A, Masud T, Orton E, Skelton DA, Timmons S, Todd C, Goodwin VA.   +13 more
europepmc   +1 more source

Anatomy of a Technology Transfer: The National Commission on Libraries and Information Science Literacy Project

, 1986
Christina Carr Young
openalex   +1 more source